Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Papa

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Biochemical Society Transactions|April 13, 2016
Dynamic imaging for CAR-T-cell therapyNia Emami-Shahri, Sophie Papa
Rheumatology (Oxford, England)|December 10, 2019
Setting the scene - a future 'epidemic' of immune-related adverse events in association with checkpoint inhibitor therapyMaria V Bermudez, Sophie Papa
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2013
Reply to A. Surbone et alJames Spicer, Henrik Moller, Sophie Papa
Nature Reviews. Clinical Oncology|April 17, 2020
Provision of cancer care during the COVID-19 pandemicJames Spicer, Charlotte Chamberlain, Sophie Papa
Methods in Molecular Biology (Clifton, N.J.)|June 15, 2015
Clinical Evaluation of ErbB-Targeted CAR T-Cells, Following Intracavity Delivery in Patients with ErbB-Expressing Solid TumorsSophie Papa, May van Schalkwyk, John Maher
Expert Opinion on Biological Therapy|June 23, 2020
PanErbB-targeted CAR T-cell immunotherapy of head and neck cancerDaniel Larcombe-Young, Sophie Papa, John Maher
BMJ Case Reports|April 6, 2019
Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitisHajir Ibraheim, Michael Green, Sophie Papa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
New Developments in Imaging Cell-Based TherapyOlivier Martinez, Jane Sosabowski, John Maher, et al.
Antibodies (Basel, Switzerland)|April 3, 2021
Utilizing Immunocytokines for Cancer TherapyErin Runbeck, Silvia Crescioli, Sophia N Karagiannis, et al.
Clinical and Experimental Dermatology|August 25, 2022
A rapidly expanding cutaneous tumour in the context of a Janus kinase inhibitor agent following allogeneic stem cell transplantAnna Davies, Jon Salisbury, Varun Mehra, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Biochemical Society Transactions|April 13, 2016
Dynamic imaging for CAR-T-cell therapyNia Emami-Shahri, Sophie Papa
Rheumatology (Oxford, England)|December 10, 2019
Setting the scene - a future 'epidemic' of immune-related adverse events in association with checkpoint inhibitor therapyMaria V Bermudez, Sophie Papa
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2013
Reply to A. Surbone et alJames Spicer, Henrik Moller, Sophie Papa
Nature Reviews. Clinical Oncology|April 17, 2020
Provision of cancer care during the COVID-19 pandemicJames Spicer, Charlotte Chamberlain, Sophie Papa
Methods in Molecular Biology (Clifton, N.J.)|June 15, 2015
Clinical Evaluation of ErbB-Targeted CAR T-Cells, Following Intracavity Delivery in Patients with ErbB-Expressing Solid TumorsSophie Papa, May van Schalkwyk, John Maher
Expert Opinion on Biological Therapy|June 23, 2020
PanErbB-targeted CAR T-cell immunotherapy of head and neck cancerDaniel Larcombe-Young, Sophie Papa, John Maher
BMJ Case Reports|April 6, 2019
Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitisHajir Ibraheim, Michael Green, Sophie Papa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
New Developments in Imaging Cell-Based TherapyOlivier Martinez, Jane Sosabowski, John Maher, et al.
Antibodies (Basel, Switzerland)|April 3, 2021
Utilizing Immunocytokines for Cancer TherapyErin Runbeck, Silvia Crescioli, Sophia N Karagiannis, et al.
Clinical and Experimental Dermatology|August 25, 2022
A rapidly expanding cutaneous tumour in the context of a Janus kinase inhibitor agent following allogeneic stem cell transplantAnna Davies, Jon Salisbury, Varun Mehra, et al.
Pageof 6